These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6403562)

  • 1. Determination of dihydroergocristine and dihydroergotamine in plasma by high-performance liquid chromatography with fluorescence detection.
    Zecca L; Bonini L; Bareggi SR
    J Chromatogr; 1983 Feb; 272(2):401-5. PubMed ID: 6403562
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of dihydroergotamine in human plasma by high-performance liquid chromatography with fluorescence detection.
    Murday M; McLean AM; Slaughter E; Couch RA
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 735(2):151-7. PubMed ID: 10670731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified solid-phase extraction method for determination of dihydroergotamine in rabbit and human serum using high-performance liquid chromatography with fluorescence detection.
    Romeijn SG; Marttin E; Verhoef JC; Merkus FW
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):227-32. PubMed ID: 9187405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of sub-nanogram amounts of dihydroergotamine in plasma and urine using liquid chromatography and fluorimetric detection with off-line and on-line solid-phase drug enrichment.
    Humbert H; Denouel J; Chervet JP; Lavene D; Kiechel JR
    J Chromatogr; 1987 Jul; 417(2):319-29. PubMed ID: 3654884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption and excretion of dihydroergocristine and dihydroergotamine in the dog.
    Marzo A; Ghirardi P; Merlo L; Marchetti G
    Farmaco Prat; 1978 Nov; 33(11):477-83. PubMed ID: 108136
    [No Abstract]   [Full Text] [Related]  

  • 6. Dihydroergotoxine: separation and determination of four components by high-performance liquid chromatography.
    Hartmann V; Rödiger M; Ableidinger W; Bethke H
    J Pharm Sci; 1978 Jan; 67(1):98-103. PubMed ID: 412946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and human pharmacokinetics of dihydroergotoxine metabolites in man: preliminary results.
    Bicalho B; Giolo JM; Lilla S; De Nucci G
    Biopharm Drug Dispos; 2008 Jan; 29(1):17-28. PubMed ID: 17941060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of methylergometrine and dihydroergotoxine in biological fluids.
    Iwamura S; Kambegawa A
    J Pharmacobiodyn; 1981 Apr; 4(4):275-81. PubMed ID: 7264872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated liquid chromatography-tandem mass spectrometry method for simultaneous determination of clopamide, reserpine and dihydroergotoxine: Application to pharmacokinetics in human plasma.
    Sharaf El-Din MM; Nassar MW; Attia KA; Demellawy MA; Kaddah MM
    J Pharm Biomed Anal; 2016 Jun; 125():236-44. PubMed ID: 27037980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a combination of raubasine, dihydroergocristine and dihydroergotamine in dogs and human beings.
    Marzo A; Ghirardi P; Parenti MA; Merlo L; Marchetti G; Cavalca L; Omboni E; Pignataro T; Ligresti A
    Farmaco Prat; 1981 Apr; 36(4):173-97. PubMed ID: 6785104
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative thin-layer chromatographic determination of dihydroergot alkaloids.
    Riedel E; Kreutz G; Hermsdorf D
    J Chromatogr; 1982 May; 229(2):417-23. PubMed ID: 7096476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative plethysmographic study of the venoconstrictor effect of dihydroergotamine and dihydroergotoxine on the deep veins of the calf in healthy subjects and patients suffering from varicosis.
    Barthel W; Grossmann K
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):458-64. PubMed ID: 7141753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of amidepin in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection.
    Stehlík P; Houbová H
    J Chromatogr; 1991 Apr; 565(1-2):477-81. PubMed ID: 1874897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute and subacute treatment with ergot drugs on the GABA system in specific brain regions.
    Pericić D
    J Pharm Pharmacol; 1981 Oct; 33(10):655-9. PubMed ID: 6117619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of furosemide and amiloride in plasma using high-performance liquid chromatography with fluorescence detection.
    Reeuwijk HJ; Tjaden UR; van der Greef J
    J Chromatogr; 1992 Mar; 575(2):269-74. PubMed ID: 1629303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New, high-sensitivity high-performance liquid chromatographic method for the determination of acyclovir in human plasma, using fluorometric detection.
    Mascher H; Kikuta C; Metz R; Vergin H
    J Chromatogr; 1992 Nov; 583(1):122-7. PubMed ID: 1484085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroergotoxine kinetics in healthy men after intravenous and oral administration.
    Woodcock BG; Loh W; Habedank WD; Rietbrock N
    Clin Pharmacol Ther; 1982 Nov; 32(5):622-7. PubMed ID: 7128002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a high-performance liquid chromatographic fluorescence method for the rapid determination of alpha-tocopherol in the plasma of cattle and pigs and its comparison with direct fluorescence and high-performance liquid chromatography-ultraviolet detection methods.
    McMurray CH; Blanchflower WJ
    J Chromatogr; 1979 Oct; 178(2):525-31. PubMed ID: 528659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC method with fluorescence detection for the determination of ligustilide in rat plasma and its pharmacokinetics.
    Zhang XY; Qiao H; Shi YB
    Pharm Biol; 2014 Jan; 52(1):21-30. PubMed ID: 24044763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ergoloid mesylate dihydroergotoxine: radioimmunoassay measurements on plasma and blood-pressure-lowering activity.
    Woodcock BG; Habedank WD; Loh W; Rietbrock N
    J Cardiovasc Pharmacol; 1984; 6(3):543-5. PubMed ID: 6202984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.